116 related articles for article (PubMed ID: 34126417)
21. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
[TBL] [Abstract][Full Text] [Related]
22. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
[TBL] [Abstract][Full Text] [Related]
23. Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
Allameh A; Moazeni-Roodi A; Harirchi I; Ravanshad M; Motiee-Langroudi M; Garajei A; Hamidavi A; Mesbah-Namin SA
Pathol Oncol Res; 2019 Oct; 25(4):1535-1543. PubMed ID: 30511108
[TBL] [Abstract][Full Text] [Related]
24. Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.
Schussel JL; Kalinke LP; Sassi LM; de Oliveira BV; Pedruzzi PA; Olandoski M; Alvares LE; Garlet GP; Trevilatto PC
Cancer Biomark; 2015; 15(1):11-7. PubMed ID: 25524937
[TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
26. ORAOV1 is amplified in oral squamous cell carcinoma.
Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
[TBL] [Abstract][Full Text] [Related]
27. Validation of methylation markers for diagnosis of oral cavity cancer.
Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
[TBL] [Abstract][Full Text] [Related]
28. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
[TBL] [Abstract][Full Text] [Related]
29. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.
Chen L; Wang D
World J Surg Oncol; 2021 Jan; 19(1):16. PubMed ID: 33468155
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
Reddy VR; Annamalai T; Narayanan V; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma.
Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H
J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma.
Sun R; Juan YC; Su YF; Zhang WB; Yu Y; Yang HY; Yu GY; Peng X
J Oral Pathol Med; 2020 Sep; 49(8):751-760. PubMed ID: 32428271
[TBL] [Abstract][Full Text] [Related]
34. Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.
Uchida K; Veeramachaneni R; Huey B; Bhattacharya A; Schmidt BL; Albertson DG
BMC Cancer; 2014 May; 14():353. PubMed ID: 24886209
[TBL] [Abstract][Full Text] [Related]
35. Aberrant promoter methylation of T-cadherin in sera is associated with a poor prognosis in oral squamous cell carcinoma.
Wang Q; Chen Y; Chen Y; Jiang J; Song X; Zhang L; He Q; Ye B; Wu L; Wu R; Lai Q; Wang D; Zhao Y
Neoplasma; 2021 May; 68(3):528-534. PubMed ID: 33567853
[TBL] [Abstract][Full Text] [Related]
36. Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham TM; Lin TK
Asian Pac J Cancer Prev; 2016; 17(1):219-23. PubMed ID: 26838213
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation of MGMT in oral carcinoma: A population-based study and meta-analysis.
Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Arch Oral Biol; 2017 Aug; 80():197-208. PubMed ID: 28458179
[TBL] [Abstract][Full Text] [Related]
38. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
39. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.
Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564
[TBL] [Abstract][Full Text] [Related]
40. Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma.
Ha S; Zhou H; Gautam M; Song Y; Wang C
Mol Genet Genomic Med; 2019 Jul; 7(7):e00783. PubMed ID: 31169368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]